Search results
Added:
1 month ago
Source:
Transcatheter Academy
An individual patient data (IPD) meta-analysis has found that using fractional flow reserve (FFR) to guide percutaneous coronary intervention (PCI) is associated with a significant reduction in major adverse events compared to a standard angiography-guided strategy. The benefit appears to be driven primarily by a reduction in peri-procedural myocardial infarction (MI).¹The PRIME Collaboration…
View more
Author(s):
Yanushka Herath
,
Judy Ranaweera
,
Thisal Semina
,
et al
Added:
2 weeks ago
Author(s):
Suzanne J Baron
Added:
1 month ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible…
View more
ESC 24: The OCCUPI Trial
Author(s):
Byeong-Keuk Kim
Added:
1 year ago
Video
Author(s):
Alexandra Frogoudaki
,
Ahmed Krimly
Added:
1 week ago
Author(s):
Mark Anderson
,
Nicolas Brozzi
,
Raul Rosenthal
,
et al
Added:
1 year ago
Added:
1 week ago
Source:
Radcliffe Cardiology
The first month following primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is a period of high risk for major adverse cardiovascular events (MACEs). The TADCLOT trial aimed to compare the efficacy of ticagrelor against a twice-daily clopidogrel regimen in this critical short-term window.¹The TADCLOT (Twice-A-Day CLOpidogrel vs Ticagrelor)…
View more
Author(s):
Carolina Álvarez-Ortega
,
Josué Daniel Gómez-Martínez
,
María Alejandra Cardona-Gallardo
,
et al
Added:
1 year ago
Author(s):
Added:
9 months ago
TIMELY is an integrated AI-based healthcare solution consisting of a certified physician platform and a patient app. It has been developed within an EU-funded project running from 2021 to 2025. TIMELY aims to assist both cardiac patients and their clinicians in personalising healthcare by evaluating risks and offering individualised exercise recommendations. The solution has been evaluated within…
View more